Angiodynamics (ANGO) Tax Provisions (2010 - 2026)
Angiodynamics' (ANGO) quarterly Tax Provisions came in at $370000.0 in Q2 2026, up 716.67% on a YoY basis from $45306.1 in Q2 2025, and up 2983.33% quarter-over-quarter from $12000.0 in Q1 2026.
Analysis
Angiodynamics (ANGO) Tax Provisions (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has reported Tax Provisions for 17 consecutive years, with $370000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Provisions rose 716.67% year-over-year to $370000.0; the trailing twelve-month figure through May 2026 stood at $442000.0 (up 1233.33% YoY), and the FY2026 full-year result was $442000.0, up 1233.33% from the prior year.
- Tax Provisions rose to $370000.0 in Q2 2026 per ANGO's latest filing, from $12000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $16.4 million in Q4 2023 and bottomed at -$12.0 million in Q1 2024.
- Historically, Tax Provisions has averaged -$563055.6 across 5 years, with a median of -$144500.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Tax Provisions soared 3007.96% in 2023, then sank 6606.15% in 2024.
- Over 5 years, Tax Provisions stood at -$565000.0 in 2022, then jumped by 3007.96% to $16.4 million in 2023, then sank by 100.67% to -$110000.0 in 2024, then soared by 95.45% to -$5000.0 in 2025, then surged by 7500.0% to $370000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $370000.0, $12000.0, and -$5000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | 596.00 Mn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 231.40 Mn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | 289.00 Mn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 288.00 Mn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 155.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 278.40 Mn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | 46.00 Mn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | 68.40 Mn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | 72.50 Mn |
| 10 | Angiodynamics | 626.21 Mn | 572.35 Mn | 46.77 Mn | 370,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 370,000.00 |
| Feb 28, 2026 | 12,000.00 |
| Nov 30, 2025 | -5,000.00 |
| Aug 31, 2025 | 65,000.00 |
| May 31, 2025 | -60,000.00 |
| Feb 28, 2025 | -2,000.00 |
| Nov 30, 2024 | -110,000.00 |
| Aug 31, 2024 | 133,000.00 |
| May 31, 2024 | -692,000.00 |
| Feb 29, 2024 | -12.00 Mn |
| Nov 30, 2023 | 16.43 Mn |
| Aug 31, 2023 | -11.02 Mn |
| May 31, 2023 | -398,000.00 |
| Feb 28, 2023 | -179,000.00 |
| Nov 30, 2022 | -565,000.00 |
| Aug 31, 2022 | -853,000.00 |
| May 31, 2022 | -455,000.00 |
| Feb 28, 2022 | -799,000.00 |
| Nov 30, 2021 | -512,000.00 |
| Aug 31, 2021 | -1.64 Mn |